| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.12B | +31.4% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥0.00B | — |
| Net income | ¥0.00B | — |
| Gross margin | 12.8% | Net margin 1.0% |
| Revenue Q/Q | -14.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.10B | 87.2% |
| R&D | ¥0.00B | 1.4% |
| SG&A | ¥0.01B | 10.3% |
| Tax & other | ¥0.00B | 2.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
九强生物 ・ 凯发电气 ・ 道氏技术 ・ 正业科技 ・ 金盾股份 ・ 迦南科技 ・ 中光防雷 ・ 伊之密 ・ 苏试试验 ・ 南华仪器 ・ ST浩丰 ・ 五洋自控
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies